| Imperial Health, Llp | |
|
501 Dr Michael Debakey Dr Lake Charles LA 70601-5724 | |
| (337) 433-8400 | |
| (337) 312-6708 |
| Full Name | Imperial Health, Llp |
|---|---|
| Speciality | Family Medicine |
| Location | 501 Dr Michael Debakey Dr, Lake Charles, Louisiana |
| Authorized Official Name and Position | Tonya Richard (ASSISTANT ADMINISTRATOR) |
| Authorized Official Contact | 3373128291 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Imperial Health, Llp 501 Dr Michael Debakey Dr Lake Charles LA 70601-5724 Ph: (337) 433-8400 | Imperial Health, Llp 501 Dr Michael Debakey Dr Lake Charles LA 70601-5724 Ph: (337) 433-8400 |
| NPI Number | 1053352401 |
|---|---|
| Provider Enumeration Date | 06/09/2006 |
| Last Update Date | 01/16/2017 |
| Medicare PECOS PAC ID | 7719886779 |
|---|---|
| Medicare Enrollment ID | O20040108000257 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053352401 | NPI | - | NPPES |
| 1016314 | Medicaid | LA |
| Provider Name | Brian C Wilder |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1558455733 PECOS PAC ID: 6709782089 Enrollment ID: I20031209000070 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | John A Digiglia |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1497717656 PECOS PAC ID: 1951200864 Enrollment ID: I20040108000544 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Jason R Morris |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1861468068 PECOS PAC ID: 0042101750 Enrollment ID: I20040323000313 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Carl Fastabend |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1568438984 PECOS PAC ID: 7810964616 Enrollment ID: I20040913000115 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Ralph M Hays |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1528039922 PECOS PAC ID: 5092760504 Enrollment ID: I20050317000624 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Samantha Ann Rider |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1053374595 PECOS PAC ID: 3072548577 Enrollment ID: I20051004000504 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Jennifer R Crawford |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1639110117 PECOS PAC ID: 6103839071 Enrollment ID: I20060718000249 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Brooke C Kennedy |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1487693644 PECOS PAC ID: 5698778025 Enrollment ID: I20060824000251 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Timothy R Gilbert |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1467568600 PECOS PAC ID: 5991703514 Enrollment ID: I20061115000127 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Michael C Turner |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1629035647 PECOS PAC ID: 5799889226 Enrollment ID: I20070322000430 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Brett Michael Cascio |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1093828113 PECOS PAC ID: 6901900513 Enrollment ID: I20070810000031 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Errol Wilder |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1790815512 PECOS PAC ID: 7214028786 Enrollment ID: I20070813000505 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Todd A Peavy |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1649205956 PECOS PAC ID: 4688767601 Enrollment ID: I20070907000302 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Laura B Stawecki |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1629122346 PECOS PAC ID: 9638264476 Enrollment ID: I20071009000210 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Amanda E Keys |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1215145164 PECOS PAC ID: 8729165360 Enrollment ID: I20080408000194 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Anna C Landry |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1639348394 PECOS PAC ID: 2961580022 Enrollment ID: I20080415000638 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Yang-tze Yoko Broussard |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1922099662 PECOS PAC ID: 5496819666 Enrollment ID: I20090204000698 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Steve Springer |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1477538619 PECOS PAC ID: 8325125941 Enrollment ID: I20100120000747 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Keane T O'neal |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1932175353 PECOS PAC ID: 4486742137 Enrollment ID: I20100316000107 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Luke Meade Williams |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1659347854 PECOS PAC ID: 1759479405 Enrollment ID: I20100416000137 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Bryan G Barootes |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1326040858 PECOS PAC ID: 5991836785 Enrollment ID: I20100622000813 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Andres J Guillermo |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1639379837 PECOS PAC ID: 8426245747 Enrollment ID: I20101211000128 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Rebecca Ellen Godare Stein |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1033412275 PECOS PAC ID: 9830378769 Enrollment ID: I20110125000635 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Benjamin Williams |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1013195395 PECOS PAC ID: 3678756947 Enrollment ID: I20110323000871 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Kara A Headington |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1720275498 PECOS PAC ID: 4789768094 Enrollment ID: I20110504000079 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Thomas Mulhearn |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1285789008 PECOS PAC ID: 9739276007 Enrollment ID: I20110726000500 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Ellendale Gabbert |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1134337017 PECOS PAC ID: 6901847474 Enrollment ID: I20110913000394 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Jared Ryan Whitehead |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1528356367 PECOS PAC ID: 2567633027 Enrollment ID: I20110914000444 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Christina Savant |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1942435151 PECOS PAC ID: 9234301102 Enrollment ID: I20111019000358 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Melissa L Rasberry |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1043451008 PECOS PAC ID: 1153597000 Enrollment ID: I20111227000685 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Bridget Catherine Loehn |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1083875850 PECOS PAC ID: 2567696230 Enrollment ID: I20131011000842 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Kari Hankins |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1154552131 PECOS PAC ID: 3678796893 Enrollment ID: I20140515001507 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Clay Lawrence Hill |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174956510 PECOS PAC ID: 3274758339 Enrollment ID: I20140702002465 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Corey Foster |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1669693867 PECOS PAC ID: 3476607433 Enrollment ID: I20140812000284 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Olivia Paige Blalock |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1598176653 PECOS PAC ID: 2264650027 Enrollment ID: I20140820002202 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Sandra E Dempsey |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1124124870 PECOS PAC ID: 3476794959 Enrollment ID: I20140924000941 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Jake Thomas Lebeau |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1174659668 PECOS PAC ID: 7517016223 Enrollment ID: I20141015001919 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Rikki L Monticello |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1356730303 PECOS PAC ID: 9931426509 Enrollment ID: I20150318002154 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Timothy J Dougherty |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1487046694 PECOS PAC ID: 7214255215 Enrollment ID: I20150422001434 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Effat Rasul |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1699086561 PECOS PAC ID: 3779717855 Enrollment ID: I20150429000800 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Juan Carlos Teran |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1346294691 PECOS PAC ID: 1759390420 Enrollment ID: I20150707001351 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Blake Joseph Leblanc |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1326365123 PECOS PAC ID: 5092022145 Enrollment ID: I20150922001671 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Casey Navarre Fontenot |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1922481779 PECOS PAC ID: 2062720709 Enrollment ID: I20150930001238 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Codie J Lee Guidry |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336506922 PECOS PAC ID: 0244535276 Enrollment ID: I20160229001603 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Meagan E Hinch |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1477901379 PECOS PAC ID: 5698060846 Enrollment ID: I20160826000806 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Kallie Holt |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1477917193 PECOS PAC ID: 0446547269 Enrollment ID: I20160922000923 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Brett Jared Goodwin |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1235457870 PECOS PAC ID: 5597033043 Enrollment ID: I20170626000499 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Benjamin Scott Fontenot |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1508283813 PECOS PAC ID: 5799057097 Enrollment ID: I20170822001448 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Jason Burklow |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1740600683 PECOS PAC ID: 0749406874 Enrollment ID: I20170913001395 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Jonathan D Rochon |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174046700 PECOS PAC ID: 7416221171 Enrollment ID: I20170919000808 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Chad Ray Hodge |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1154854255 PECOS PAC ID: 3577821610 Enrollment ID: I20171220000211 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Amanda N Partin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750890349 PECOS PAC ID: 5395006118 Enrollment ID: I20180219001191 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Justin William Rudd |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1174889794 PECOS PAC ID: 5890091961 Enrollment ID: I20180717003138 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Melissa Ann Marcantel |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1720555188 PECOS PAC ID: 6507100724 Enrollment ID: I20181129000265 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Parker G Lavigne |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1467816595 PECOS PAC ID: 9234425380 Enrollment ID: I20190613000310 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Andrew Bradberry |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1972954006 PECOS PAC ID: 1052606795 Enrollment ID: I20190724000172 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Charlotte R Ardoin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1841857778 PECOS PAC ID: 6507291242 Enrollment ID: I20200127001663 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Dorothy Renee Thornton |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225640295 PECOS PAC ID: 9537588421 Enrollment ID: I20200925001402 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Emily A Presnull |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1477171312 PECOS PAC ID: 8224458906 Enrollment ID: I20201019001972 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Tyler J Zachary |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1386025336 PECOS PAC ID: 5193031276 Enrollment ID: I20201103000182 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Cynthia Trahan Cox |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1043867997 PECOS PAC ID: 4284048893 Enrollment ID: I20210121002908 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Devin G Morris |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225627565 PECOS PAC ID: 3476968652 Enrollment ID: I20210222000539 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Wade Gillard |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1982223087 PECOS PAC ID: 5698180685 Enrollment ID: I20210225001706 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Marissa Ann De La Paz |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1871090456 PECOS PAC ID: 2961748389 Enrollment ID: I20210610001807 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Christine C Palma |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1932696754 PECOS PAC ID: 7911309737 Enrollment ID: I20210715001733 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Prasanna Sugathan |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1598847733 PECOS PAC ID: 6709772593 Enrollment ID: I20211007001258 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Lacy Jaye Simmons |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1811653785 PECOS PAC ID: 9931590650 Enrollment ID: I20220106001239 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Kyle Mauk |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1639599053 PECOS PAC ID: 2365714052 Enrollment ID: I20220725003196 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Mary Samantha Darbonne |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1932781747 PECOS PAC ID: 5395127070 Enrollment ID: I20220727002120 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Jennifer Lynn Bunch |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1962134999 PECOS PAC ID: 7911380845 Enrollment ID: I20220810001435 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Julie R Fruge |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1487373213 PECOS PAC ID: 5890165211 Enrollment ID: I20221229002332 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Victoria Lynn Mcdaniel |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1326747080 PECOS PAC ID: 7719352251 Enrollment ID: I20230413002883 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Ashley Babineaux |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1356021877 PECOS PAC ID: 6709240849 Enrollment ID: I20230908000113 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Blair Alizabeth Snider |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1952021412 PECOS PAC ID: 5890159792 Enrollment ID: I20230911003832 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
| Provider Name | Angela Meche |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1235886458 PECOS PAC ID: 5991150641 Enrollment ID: I20231016002095 |
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
News Archive
New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions.
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.
› Verified 6 days ago
Lake Charles Medical Services, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1717 Oak Park Blvd, Lake Charles, LA 70601 Phone: 337-582-7632 Fax: 337-582-7656 | |
Family Medical Center. Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2750 Aster St, Lake Charles, LA 70601 Phone: 337-478-2650 Fax: 337-478-8183 | |
Cardiovascular Outpatient Center Of Southwest Louisiana Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 401 Dr Michael Debakey Dr, Suite 300, Lake Charles, LA 70601 Phone: 337-602-9991 | |
Washington-marion Sbhc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2802 Pineview St, Lake Charles, LA 70615 Phone: 337-217-4540 Fax: 337-439-5029 | |
Headache And Wellness Center Of Southwest Louisiana, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 803 W Bayou Pines Dr Ste B, Lake Charles, LA 70601 Phone: 337-508-2333 | |
Kndl Partners Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4200 Nelson Rd, Lake Charles, LA 70605 Phone: 337-475-4748 Fax: 337-944-4421 |